Login to Your Account

Newcomer Alucent to begin trials for combo drug/device to treat PVD

By Katie Pfaff
Staff Writer

Friday, May 19, 2017

Salt Lake City-based Alucent Medical Inc. reported it has been granted FDA approval to begin phase I trials of a combination drug/device intended to treat peripheral vascular disease (PVD).

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription